Ultrasound detection of visceral adhesion after intraperitoneal ventral hernia treatment: a comparative study of protected versus unprotected meshes.
Intraperitoneal (IP) ventral hernia repair has been proposed with the advantages of reducing dissection, operative time, and postoperative pain. The IP position of the mesh is suspected of increasing the risk of visceral adhesion and inducing complications. To overcome these drawbacks, a mesh protected on one side by a hydrophilic resorbable film (Parietex Composite) has been validated. Using a previously described ultrasound procedure, the purpose of this study was to compare the rate of visceral adhesion after intraperitoneal placement of a polyester mesh versus this protected mesh. Fifty-one patients who received a Parietex Composite mesh were prospectively compared to a retrospective series of 22 consecutive asymptomatic patients who received a Mersilene mesh. To objectively assess visceral adhesion toward the abdominal wall, an ultrasound (US) specific examination was firstly validated and secondly used to evaluate the adhesion incidence in both groups. Both groups were equivalent in terms of inclusion criteria and body mass index (BMI). Pre-operative US versus perioperative macroscopical findings determined the following parameters: sensitivity 83%, accuracy 78%, negative predictive value 81%. Using this procedure, 77% of the patients exhibited visceral adhesion to the mesh in the Mersilene group, against 18% in the Parietex Composite group (P<0.001, chi-square). US examination represents a suitable tool to evaluate postoperative adhesions to the abdominal wall. Using this procedure, a significant reduction of visceral adhesion in the Parietex Composite group was shown.
Arnaud
J P
JP
Department of Visceral Surgery, CHU Angers, 4 rue Larrey, France. jparnaud@chu-angers.fr
Hennekinne-Mucci
S
S
Pessaux
P
P
Tuech
J J
JJ
Aube
C
C
D020099:Coated Materials, Biocompatible / Q000009:adverse effects*; D015331:Cohort Studies; D003094:Collagen / Q000009:adverse effects; D005990:Glycerol / Q000009:adverse effects; D006555:Hernia, Ventral / Q000601:surgery*; D006801:Humans; D008875:Middle Aged; D010529:Peritoneal Cavity / Q000000981:diagnostic imaging / Q000601:surgery; D011091:Polyesters / Q000009:adverse effects*; D011092:Polyethylene Glycols / Q000009:adverse effects; D011093:Polyethylene Terephthalates / Q000009:adverse effects*; D011446:Prospective Studies; D013526:Surgical Mesh / Q000009:adverse effects*; D013514:Surgical Procedures, Operative / Q000009:adverse effects* / Q000379:methods*; D000267:Tissue Adhesions / Q000000981:diagnostic imaging* / Q000209:etiology; D014463:Ultrasonography
D020099:Coated Materials, Biocompatible; D011091:Polyesters; D011093:Polyethylene Terephthalates; C059821:atelocollagen; C025539:Lavsan; D011092:Polyethylene Glycols; D003094:Collagen; D005990:Glycerol